NIH Offers Licensing Agreements to Commercialize Technologies - NIH makes available a full range of licenses for commercial evaluation and for the sale of commercial products and services. - BioPharm

ADVERTISEMENT

NIH Offers Licensing Agreements to Commercialize Technologies
NIH makes available a full range of licenses for commercial evaluation and for the sale of commercial products and services.


BioPharm International
Volume 20, Issue 3

14. For a list of the NIH Technology Development Coordinators for each of the Institutes and Centers and their contact information, see http://www.ott.nih.gov/nih_staff/tdc.html

15. Conflict of Interest Information and Resources. Washington, DC: NIH. Available from: http://www.nih.gov/about/ethics_COI.htm

16. 15 USC 3710a.

17. 28 USC 209(e).

18. For these and other success stories, see http://www.ott.nih.gov/about_nih/success_stories.html

19. Cooperative Research and Development Agreements and Material Transfer Agreements. Washington, DC: NIH. Available from: http://www.ott.nih.gov/cradas/model_agree.html

20. The Government won a court challenge to keep company proprietary information from disclosure under the Freedom of Information Act. Public Citizen Health Research Group vs. National Institutes of Health and Johnson & Johnson, U.S. Ct D.C., March 12, 2002. Available from: http://www.ott.nih.gov/foia/PCHRGopinion.pdf


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here